Tobramycin Injection, Powder, For Solution
Product Images NDC 63323-303

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 63323-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Tobramycin sulfate, depicting its molecular composition with amino and hydroxyl functional groups as part of the compound's sugar rings.*

FDA Label Image

Tray (Tray)

Label for Tobramycin injection powder for solution, USP, with a strength equivalent to 1.2 g Tobramycin. The label indicates it is a pharmacy bulk package not for direct infusion, provided by NOVAPLUS, manufactured by APP Pharmaceuticals, LLC, and submitted by Fresenius Kabi USA, LLC. The label includes storage instructions and the product NDC 63323-303-55.*

FDA Label Image

Vial (Vial)

Tobramycin for Injection, USP label indicating a pharmacy bulk package not for direct infusion. The label shows the equivalent amount of 1.2 g Tobramycin, with restriction for prescription use only. The label features blue and red text boxes on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.